Tradestie Institutional Equity Comparison Engine

HAE vs UFPT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HAE Overall Edge

HAE Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Haemonetics Corporation (HAE) driven by superior Valuation, Momentum & Technical, Options & Structure while UFPT counters with relative strength in Growth & Margin. Fundamentally, HAE trades at 22.9x Forward P/E with 18.8% operating margin (+9.3% YoY revenue) versus UFPT at 24.7x Forward P/E and 15.4% operating margin (+11.6% YoY). In options structure, HAE sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro) against UFPT sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner HAE
HAE 22.9x vs UFPT 24.7x Fwd P/E
Growth & Margin Winner UFPT
Op Margin 18.8% vs 15.4% ยท YoY +9.3% vs +11.6%
Momentum & Technical Winner HAE
1Y +64.2% vs +27.4% ยท 52W Pos 87% vs 74%
Options & Structure Winner HAE
UNCLASSIFIED (2nd %ile IV) vs UNCLASSIFIED (3rd %ile IV)
HAE NYSE
Haemonetics Corporation
Surgical & Medical Instruments & Apparatus
$121.34
-1.3% 1D
Market Cap $5.6B
1M Return +2.59%
1Y Return +64.17%
Forward P/E 22.9x
Unified AI Score
51.4 / 100 HOLD
Tech 53.0 Fund 47.0 Flow 50.0 Mom 36.0
UFPT NASDAQ
UFP Technologies Inc
Surgical & Medical Instruments & Apparatus
$298.54
-2.14% 1D
Market Cap $2.4B
1M Return +2.36%
1Y Return +27.42%
Forward P/E 24.7x
Unified AI Score
42.6 / 100 HOLD
Tech 25.0 Fund 37.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: HAE +64.17% UFPT +27.42% Spread: +36.75 pp (HAE Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
HAE TTM Op. Margin: 18.8% UFPT TTM Op. Margin: 15.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HAE vs UFPT. Trailing 12-month operating profitability (HAE 18.8% vs UFPT 15.4%) and valuation multiples (HAE 22.9x vs UFPT 24.7x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: HAE (6) vs UFPT (4)
Institutional Metric HAE UFPT Criterion Row Winner
Market Capitalization Scale $5.6B $2.4B Larger Scale HAE
Trailing P/E Ratio Valuation 54.4x 31.2x Lower Multiple UFPT
Forward P/E Ratio Valuation 22.9x 24.7x Lower Multiple HAE
Revenue Growth (YoY) Growth +9.3% +11.6% Higher Growth UFPT
Operating Margin (TTM) Profitability 18.8% 15.4% Higher Margin HAE
Net Profit Margin Profitability 7.5% 11.8% Higher Margin UFPT
Return on Equity (ROE) Capital Efficiency 11.9% 17.2% Higher ROE UFPT
52-Week Range Position Momentum 87% ($51โ€“$132) 74% ($174โ€“$342) Stronger Trend HAE
Beta / 30D Volatility Risk Regime 0.27ฮฒ ยท 32% Vol 1.64ฮฒ ยท 77% Vol Lower Realized Risk HAE
Unified Institutional Score Composite Signal 51.4 / 100 (HOLD) 42.6 / 100 (HOLD) Higher Composite HAE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full HAE vs UFPT Buy Guide
HAE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live HAE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
UFPT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live UFPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither HAE nor UFPT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.